{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:28:25Z","timestamp":1773422905469,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00115-018-0601-6","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T13:29:01Z","timestamp":1535722141000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Das Darmmikrobiom bei der Parkinson-Krankheit","The gut microbiome in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"90","author":[{"given":"J. R.","family":"Bedarf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Goeser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"W\u00fcllner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"issue":"10","key":"601_CR1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.26702","volume":"31","author":"L Antunes","year":"2016","unstructured":"Antunes L, Frasquilho S, Ostaszewski M, Weber J, Longhino L, Antony P et al (2016) Similar alpha-Synuclein staining in the colon mucosa in patients with Parkinson\u2019s disease and controls. Mov Disord 31(10):1567\u20131570","journal-title":"Mov Disord"},{"issue":"1","key":"601_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L\u2011DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. \n                    https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"issue":"9","key":"601_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molmed.2014.05.002","volume":"20","author":"YE Borre","year":"2014","unstructured":"Borre YE, O\u2019Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014) Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20(9):509\u2013518","journal-title":"Trends Mol Med"},{"issue":"11","key":"601_CR4","doi-asserted-by":"publisher","first-page":"a023630","DOI":"10.1101\/cshperspect.a023630","volume":"8","author":"H Braak","year":"2016","unstructured":"Braak H, Del Tredici K (2016) Potential pathways of abnormal tau and \u03b1\u2011Synuclein dissemination in sporadic Alzheimer\u2019s and Parkinson\u2019s diseases. Cold Spring Harb Perspect Biol 8(11):a23630\u20131. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a023630","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"601_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrmicro2876","volume":"10","author":"SM Collins","year":"2012","unstructured":"Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10(11):735\u2013742","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"601_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41564-017-0072-8","volume":"3","author":"PI Costea","year":"2018","unstructured":"Costea PI et\u00a0al (2018) Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 3(1):8\u201316. \n                    https:\/\/doi.org\/10.1038\/s41564-017-0072-8","journal-title":"Nat Microbiol"},{"key":"601_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H et\u00a0al (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 50:42\u201348","journal-title":"Neurobiol Dis"},{"issue":"1","key":"601_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/2049-632X.12170","volume":"71","author":"J Dingemans","year":"2014","unstructured":"Dingemans J et al (2014) The deletion of tonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas Aeruginosa to the cystic fibrosis lung. Pathog Dis 71(1):26\u201338","journal-title":"Pathog Dis"},{"key":"601_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3389\/fmicb.2016.00713","volume":"7","author":"C Engels","year":"2016","unstructured":"Engels C, Ruscheweyh HJ, Beerenwinkel N, Lacroix C, Schwab C (2016) The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation. Front Microbiol 7:713. \n                    https:\/\/doi.org\/10.3389\/fmicb.2016.00713","journal-title":"Front Microbiol"},{"issue":"7","key":"601_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E et\u00a0al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965\u2013977","journal-title":"Nat Neurosci"},{"issue":"22","key":"601_CR11","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110(22):9066\u20139071","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"601_CR12","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6(12):e28032","journal-title":"PLoS ONE"},{"issue":"9","key":"601_CR13","doi-asserted-by":"publisher","first-page":"e74963","DOI":"10.1371\/journal.pone.0074963","volume":"8","author":"BP Ganesh","year":"2013","unstructured":"Ganesh BP, Klopfleisch R, Loh G, Blaut M (2013) Commensal Akkermansia muciniphila exacerbates gut inflammation in salmonella Typhimurium-infected gnotobiotic mice. PLoS ONE 8(9):e74963. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0074963","journal-title":"PLoS ONE"},{"issue":"11","key":"601_CR14","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M (2015) Intestinal Dysbiosis and lowered serum Lipopolysaccharide-binding protein in Parkinson\u2019s disease. PLoS ONE 10(11):e142164. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0142164","journal-title":"PLoS ONE"},{"issue":"1","key":"601_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A, Pandey U, Wicke T, Sixel-D\u00f6ring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P (2018) The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88\u201398. \n                    https:\/\/doi.org\/10.1002\/mds.27105","journal-title":"Mov Disord"},{"issue":"7","key":"601_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","volume":"26","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A, Wilmes P (2018) Human gut Microbiome: function matters. Trends Microbiol 26(7):563\u2013574. \n                    https:\/\/doi.org\/10.1016\/j.tim.2017.11.002","journal-title":"Trends Microbiol"},{"issue":"Suppl 1","key":"601_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.13593","volume":"139","author":"DG Hernandez","year":"2016","unstructured":"Hernandez DG, Reed X, Singleton AB (2016) Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J\u00a0Neurochem 139(Suppl 1):59\u201374. \n                    https:\/\/doi.org\/10.1111\/jnc.13593","journal-title":"J Neurochem"},{"issue":"1","key":"601_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2049-2618-2-30","volume":"2","author":"F Hildebrand","year":"2014","unstructured":"Hildebrand F et al (2014) LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome 2(1):30. \n                    https:\/\/doi.org\/10.1186\/2049-2618-2-30","journal-title":"Microbiome"},{"issue":"5","key":"601_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749. \n                    https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"601_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner F, K\u00fcnstner A, M\u00fcller SH, K\u00fcnzel S, Zeuner KE, Margraf NG, Deuschl G, Baines JF, Kuhlenb\u00e4umer G (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u201345. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2017.04.019","journal-title":"Brain Res"},{"issue":"10","key":"601_CR21","doi-asserted-by":"publisher","first-page":"e76520","DOI":"10.1371\/journal.pone.0076520","volume":"8","author":"CS Kang","year":"2013","unstructured":"Kang CS, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK et al (2013) Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8(10):e76520","journal-title":"PLoS ONE"},{"issue":"5","key":"601_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ et al (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662\u2013671","journal-title":"Cell Host Microbe"},{"issue":"10","key":"601_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB et\u00a0al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u20131360","journal-title":"Mov Disord"},{"issue":"11","key":"601_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease \u2013 the gut-brain axis and environmental factors. Nat Rev Neurol 11(11):625\u2013636. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2015.197","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"601_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G et\u00a0al (2016) CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 22(6):598\u2013605. \n                    https:\/\/doi.org\/10.1038\/nm.4102","journal-title":"Nat Med"},{"issue":"11","key":"601_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B (2017) Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 60(11):1223\u20131233. \n                    https:\/\/doi.org\/10.1007\/s11427-016-9001-4","journal-title":"Sci China Life Sci"},{"issue":"1","key":"601_CR27","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1038\/srep13888","volume":"5","author":"H Luan","year":"2015","unstructured":"Luan H, Liu LF, Tang Z, Zhang M, Chua KK, Song JX et\u00a0al (2015) Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson\u2019s disease. Sci Rep 5(1):13888. \n                    https:\/\/doi.org\/10.1038\/srep13888","journal-title":"Sci Rep"},{"issue":"24 Pt A","key":"601_CR28","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1016\/j.febslet.2015.10.023","volume":"589","author":"E Luna","year":"2015","unstructured":"Luna E, Luk KC (2015) Bent out of shape: alpha-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson\u2019s disease. Febs Lett 589(24 Pt A):3749\u20133759","journal-title":"Febs Lett"},{"issue":"6","key":"601_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MCO.0b013e32833eebe5","volume":"13","author":"K Meijer","year":"2010","unstructured":"Meijer K, de Vos P, Priebe MG (2010) Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr Opin Clin Nutr Metab Care 13(6):715\u2013721","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"601_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fcell.2015.00085","volume":"3","author":"OB Parks","year":"2015","unstructured":"Parks OB, Pociask DA, Hodzic Z, Kolls JK, Good M (2015) Interleukin-22 signaling in the regulation of intestinal health and disease. Front Cell Dev Biol 3:85\u201313. \n                    https:\/\/doi.org\/10.3389\/fcell.2015.00085","journal-title":"Front Cell Dev Biol"},{"key":"601_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.parkreldis.2017.02.026","volume":"38","author":"PAB Pereira","year":"2017","unstructured":"Pereira PAB, Aho VTE, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2017) Oral and nasal microbiota in Parkinson\u2019s disease. Parkinsonism Relat Disord 38:61\u201367. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.026","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"601_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov VA, Saltykova IV, Zhukova IA, Alifirova VM, Zhukova NG, Dorofeeva YB, Tyakht AV, Kovarsky BA, Alekseev DG, Kostryukova ES, Mironova YS, Izhboldina OP, Nikitina MA, Perevozchikova TV, Fait EA, Babenko VV, Vakhitova MT, Govorun VM, Sazonov AE (2017) Analysis of gut Microbiota in patients with Parkinson\u2019s disease. Bull Exp Biol Med 162(6):734\u2013737. \n                    https:\/\/doi.org\/10.1007\/s10517-017-3700-7","journal-title":"Bull Exp Biol Med"},{"issue":"6","key":"601_CR33","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018.e12","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE et\u00a0al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a\u00a0model of Parkinson\u2019s disease. Cell 167(6):1469\u20131480. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.e12","journal-title":"Cell"},{"key":"601_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.02.008","volume":"302","author":"V Sanchez-Guajardo","year":"2015","unstructured":"Sanchez-Guajardo V, Tentillier N, Romero-Ramos M (2015) The relation between alpha-synuclein and microglia in Parkinson\u2019s disease: Recent developments. Neuroscience 302:47\u201358","journal-title":"Neuroscience"},{"issue":"3","key":"601_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E et\u00a0al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358","journal-title":"Mov Disord"},{"issue":"1","key":"601_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H et\u00a0al (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128\u2013139. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2013.12.007","journal-title":"Immunity"},{"issue":"41","key":"601_CR37","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","volume":"37","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Parkinson\u2019s disease is not simply a\u00a0Prion disorder. J\u00a0Neurosci 37(41):9799\u20139807. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1787-16.2017","journal-title":"J Neurosci"},{"key":"601_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"601_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J (2016) Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65(1):57\u201362. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2015-309618","journal-title":"Gut"},{"issue":"3","key":"601_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3945\/ajcn.116.146928","volume":"105","author":"SM Vanegas","year":"2017","unstructured":"Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S, Koecher K, Karl JP, Thomas M, Dolnikowski G, Li L, Saltzman E, Wu D, Meydani SN (2017) Substituting whole grains for refined grains in a\u00a06-wk randomized trial has a\u00a0modest effect on gut microbiota and immune and inflammatory markers of healthy adults. Am J Clin Nutr 105(3):635\u2013650. \n                    https:\/\/doi.org\/10.3945\/ajcn.116.146928","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"601_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1574-6941.2011.01252.x","volume":"79","author":"J Vermeiren","year":"2012","unstructured":"Vermeiren J, Van den Abbeele P, Laukens D, Vigsnaes LK, De Vos M, Boon N et\u00a0al (2012) Decreased colonization of fecal Clostridium coccoides\/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. Fems Microbiol Ecol 79(3):685\u2013696. \n                    https:\/\/doi.org\/10.1111\/j.1574-6941.2011.01252.x","journal-title":"Fems Microbiol Ecol"},{"issue":"Suppl 1","key":"601_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jnc.13646","volume":"139","author":"U W\u00fcllner","year":"2016","unstructured":"W\u00fcllner U, Kaut O, deBoni L, Piston D, Schmitt I (2016) DNA methylation in Parkinson\u2019s disease. J\u00a0Neurochem 139(Suppl 1):108\u2013120. \n                    https:\/\/doi.org\/10.1111\/jnc.13646","journal-title":"J Neurochem"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0601-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T11:13:58Z","timestamp":1567250038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0601-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0601-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"31 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.R.\u00a0Bedarf, F.\u00a0Hildebrand, F.\u00a0Goeser, P.\u00a0Bork und U.\u00a0W\u00fcllner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}